Open AccessSafety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents
Author(s) -
Mark J. Eisenberg,
Pierre R. Richard,
Danielle Libersan,
Kristian B. Filion
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.813667
Subject(s) - medicine , discontinuation , drug , term (time) , surgery , intensive care medicine , pharmacology , physics , quantum mechanics
Antiplatelet therapy is often discontinued in patients with drug-eluting stents who are undergoing surgical procedures. However, discontinuation of antiplatelet therapy is an important risk factor for late stent thrombosis. Our objective was to examine the safety of short-term discontinuation of antiplatelet therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom